ArticleJournal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine2026
Obstructive sleep apnea comorbid with insomnia symptoms and objective short sleep duration is associated with incident hypertension.
Article in Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Beyond respiratory control in COMISA: Towards precision phenotyping in PAP-based therapies.Sleep medicine reviews · 2026Article
- Comorbid Insomnia and Sleep Apnea Mechanistic Convergence, Phenotypic Heterogeneity, and Clinical Implications.Current sleep medicine reports · 2026Article
- Association between COMISA and cardiovascular disease: Evidence from the TURKAPNE registry.PloS one · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeCo-morbid insomnia and obstructive sleep apnea (COMISA) poses greater cardiovascular risks than either condition alone. We investigated whether COMISA associated with insomnia with short sleep duration (ISSD) phenotype is associated with an increased risk of incident hypertension in a large random general population sample.
methodsFrom the 1741 participants of the Penn State Adult Cohort, 1395 were followed-up after 7.5 years and 786 did not have hypertension at baseline. Hypertension was determined by a self-report of receiving treatment for high blood pressure. Insomnia symptoms were defined as either a complaint of chronic insomnia lasting ≥ 1 year or a complaint of difficulty falling asleep, staying asleep, nonrestorative sleep, or early morning awakening. All subjects underwent 8-h in-laboratory polysomnography. Obstructive sleep apnea was defined as an obstructive apnea/hypopnea index ≥ 5 event/h. Objective short sleep duration was defined as < 6 h sleep.
resultsThe mean age of the study population was 47.5 ± 12.7 years and 51.3% were women. Compared to good sleepers, the highest risk of incident hypertension was in the COMISA with ISSD phenotype (OR = 4.25, 95%CI = 1.52-11.90), followed by OSA-alone (OR = 3.31, 95%CI = 1.85-5.92) and ISSD (OR = 2.27, 95%CI = 1.29-4). The insomnia with normal sleep duration phenotype alone or with OSA (COMISA) was not significantly associated with incident hypertension.
conclusionsThe additive effect of COMISA on hypertension risk is associated with the ISSD phenotype, the most severe biological phenotype of insomnia. Obtaining objective sleep duration in addition to apnea/hypopnea and/or oxygen saturation indices may lead to a more accurate diagnosis and treatment of COMISA.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.